NCT06546475View on ClinicalTrials.gov

A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine

PHASE4Not yet recruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

August 1, 2024

Primary Completion Date

July 31, 2027

Study Completion Date

July 31, 2027

Conditions
Psychosis
Interventions
DRUG

N-Acetylcysteine

regular dose or high dose add-on

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT06546475 - A Pilot Trial of Tapering Antipsychotics for Patients in Remitted Psychosis Co-administering With N-Acetylcysteine | Biotech Hunter | Biotech Hunter